Innovative Product Portfolio Rijuven offers a comprehensive platform of medical and consumer health devices, including FDA-cleared pediatric ECG devices like the CardioSleeve, demonstrating a strong focus on connected health technology suitable for clinical and home environments.

Growth Potential With annual revenues estimated between 1 million and 10 million and recent equity financing of over 2 million dollars, Rijuven is positioned for scaling its innovative health devices, presenting opportunities for sales expansion into pediatric and telehealth markets.

Market Focus Targeting pediatric care and health analytics, Rijuven’s devices align well with the rising telemedicine and remote monitoring trends, allowing strategic partnerships with healthcare providers and systems seeking advanced diagnostic tools.

Technology Edge Utilizing a modern tech stack with Ruby on Rails and cloud-based tools, Rijuven's platform enables integration of telemedicine capabilities and health data analytics, providing a competitive advantage for partners interested in innovative health tech solutions.

Strategic Opportunities Given their small team size but ambitious product ecosystem, there are significant sales potential in providing complementary hardware, software integrations, and distribution channels to accelerate market penetration in connected health devices.